Psyence Biomedical Ltd. - Warrants (25/01/2029) Common Stock

Psyence Biomedical Ltd. - Warrants (25/01/2029) posts a common stock of $69M as of September 2025. That compares with $53M in the prior-year period — up 30.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Psyence Biomedical Ltd. - Warrants (25/01/2029)'s common stock was $53M. The latest reading is $69M — a 30.1% year-over-year increase (period ending September 2025). Use the history and growth charts on this page for a longer lookback.

Common Stock is one piece of Psyence Biomedical Ltd. - Warrants (25/01/2029)'s financial statement story. At $69M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PBMWW's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Psyence Biomedical Ltd. - Warrants (25/01/2029)'s other metric pages and overview cover the third.